Ftse Mib
35.854,07
-0,57%
DAX
21.303,82
1,25%
S&P 500
6.086,37
0,61%
NASDAQ
20.009,34
1,28%
Bitcoin
102.524,05
-1,07%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Addex Therapeutics Ltd (0QNV) Addex Therapeutics Ltd (0QNV) Notizie

0QNV

Addex Therapeutics (0QNV)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0QNV
DataOraFonteTitoloSimboloCompagnia
08/01/202507:00UK RegulatoryAddex to Present at the 2025 Swiss Equities Baader ConferenceLSE:0QNVAddex Therapeutics Ltd
22/11/202407:00UK RegulatoryAddex Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateLSE:0QNVAddex Therapeutics Ltd
11/11/202407:00UK RegulatoryAddex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024LSE:0QNVAddex Therapeutics Ltd
30/09/202407:00UK RegulatoryAddex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate UpdateLSE:0QNVAddex Therapeutics Ltd
19/09/202407:00UK RegulatoryAddex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net ProfitLSE:0QNVAddex Therapeutics Ltd
04/09/202407:00UK RegulatoryAddex to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceLSE:0QNVAddex Therapeutics Ltd
27/08/202407:00UK RegulatoryAddex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research CollaborationLSE:0QNVAddex Therapeutics Ltd
22/07/202407:00UK RegulatoryAddex’s Partner Discontinues ADX71149 development in EpilepsyLSE:0QNVAddex Therapeutics Ltd
15/07/202407:00UK RegulatoryAddex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)LSE:0QNVAddex Therapeutics Ltd
12/07/202407:00UK RegulatoryAddex To Present at the Thirteenth London International Cough Symposium (13th LICS)LSE:0QNVAddex Therapeutics Ltd
01/07/202407:00UK RegulatoryAddex Shareholders Approve All Resolutions at Annual General MeetingLSE:0QNVAddex Therapeutics Ltd
06/06/202407:00UK RegulatoryAddex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate UpdateLSE:0QNVAddex Therapeutics Ltd
05/06/202407:00UK RegulatoryAddex Convenes Annual General Meeting 2024LSE:0QNVAddex Therapeutics Ltd
31/05/202407:00UK RegulatoryAddex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024LSE:0QNVAddex Therapeutics Ltd
08/05/202407:00UK RegulatoryAddex to Present at Bio€quity Europe 2024LSE:0QNVAddex Therapeutics Ltd
29/04/202407:00UK RegulatoryAddex Provides Update on ADX71149 Phase 2 Epilepsy StudyLSE:0QNVAddex Therapeutics Ltd
19/04/202407:00UK RegulatoryAddex to Present at the Swiss Biotech Day 2024LSE:0QNVAddex Therapeutics Ltd
18/04/202407:00UK RegulatoryAddex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate UpdateLSE:0QNVAddex Therapeutics Ltd
11/04/202407:00UK RegulatoryAddex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024LSE:0QNVAddex Therapeutics Ltd
03/04/202407:00UK RegulatoryAddex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological DisordersLSE:0QNVAddex Therapeutics Ltd
14/03/202407:00UK RegulatoryAddex to Present at the Bio-Europe Spring 2024 ConferenceLSE:0QNVAddex Therapeutics Ltd
31/01/202407:00UK RegulatoryAddex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.LSE:0QNVAddex Therapeutics Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0QNV

La tua Cronologia

NASDAQ
FCBC
First Community Bancshares
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network